Prezzo azioni Immune Pharmaceuticals, Inc. OTC Markets
Azioni
IMNPQ
US45254C2008
Prodotti farmaceutici
Tempo differito
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
- USD | -.--% | -.--% | -23,08% |
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | 37 | 12/04/21 | |
Devin J. Shaw
DFI | Director of Finance/CFO | 37 | 13/04/21 |
John Zhang
CTO | Chief Tech/Sci/R&D Officer | - | 11/12/17 |
Amministratori | Titolo | Età | Da |
---|---|---|---|
David Sidransky
BRD | Director/Board Member | 64 | - |
Tony Fiorino
BRD | Director/Board Member | 56 | 15/08/17 |
John A. Neczesny
BRD | Director/Board Member | 60 | 02/02/16 |
Variaz. 1 gen. | Capi. | |
---|---|---|
+34,13% | 701 Mrd | |
+26,24% | 571 Mrd | |
+1,25% | 381 Mrd | |
+21,17% | 334 Mrd | |
+17,05% | 319 Mrd | |
+0,74% | 210 Mrd | |
+2,95% | 210 Mrd | |
-6,05% | 201 Mrd | |
-3,24% | 157 Mrd |
- Borsa
- Azioni
- Azione Immune Pharmaceuticals, Inc.
- Azione Immune Pharmaceuticals, Inc. - OTC Markets